Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | PROF |
---|---|---|
09:44 ET | 100 | 7.78 |
10:08 ET | 300 | 7.54 |
10:29 ET | 1000 | 7.7493 |
11:09 ET | 200 | 7.7 |
11:16 ET | 100 | 7.595 |
11:18 ET | 100 | 7.565 |
11:20 ET | 100 | 7.5642 |
11:21 ET | 1700 | 7.5994 |
11:23 ET | 466 | 7.54 |
11:25 ET | 100 | 7.54 |
11:36 ET | 100 | 7.555 |
11:38 ET | 100 | 7.56 |
11:41 ET | 200 | 7.56 |
11:48 ET | 100 | 7.56 |
12:12 ET | 1174 | 7.53 |
12:14 ET | 200 | 7.52 |
12:21 ET | 330 | 7.53 |
12:33 ET | 800 | 7.5285 |
12:37 ET | 1400 | 7.47 |
12:42 ET | 1600 | 7.47 |
12:44 ET | 3100 | 7.45 |
12:46 ET | 210 | 7.48 |
12:48 ET | 100 | 7.47 |
12:50 ET | 100 | 7.4604 |
12:53 ET | 1670 | 7.51 |
12:55 ET | 100 | 7.48 |
01:08 ET | 3345 | 7.5262 |
01:11 ET | 500 | 7.55 |
01:22 ET | 300 | 7.55 |
01:29 ET | 100 | 7.59 |
01:31 ET | 3000 | 7.555 |
01:44 ET | 889 | 7.55 |
01:47 ET | 100 | 7.59 |
01:51 ET | 100 | 7.565 |
01:54 ET | 1000 | 7.55 |
01:58 ET | 100 | 7.55 |
02:03 ET | 200 | 7.6 |
02:16 ET | 502 | 7.5926 |
02:21 ET | 100 | 7.59 |
02:23 ET | 100 | 7.56 |
02:25 ET | 100 | 7.59 |
02:30 ET | 250 | 7.5695 |
02:38 ET | 100 | 7.54 |
02:41 ET | 300 | 7.54 |
02:43 ET | 100 | 7.54 |
02:45 ET | 200 | 7.53 |
02:52 ET | 100 | 7.59 |
02:57 ET | 500 | 7.565 |
02:59 ET | 1450 | 7.54 |
03:01 ET | 2152 | 7.49 |
03:03 ET | 2000 | 7.45 |
03:08 ET | 100 | 7.55 |
03:17 ET | 285 | 7.505 |
03:24 ET | 100 | 7.51 |
03:28 ET | 100 | 7.515 |
03:30 ET | 1400 | 7.515 |
03:32 ET | 100 | 7.54 |
03:39 ET | 100 | 7.6 |
03:42 ET | 700 | 7.5744 |
03:44 ET | 2500 | 7.565 |
03:48 ET | 200 | 7.565 |
03:50 ET | 100 | 7.565 |
03:51 ET | 100 | 7.6 |
03:53 ET | 700 | 7.565 |
03:55 ET | 100 | 7.565 |
03:57 ET | 100 | 7.59 |
04:00 ET | 1111 | 7.55 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Profound Medical Corp | 260.2M | 0.0x | --- |
Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low -, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (BPH); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. It is also commercializing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $260.2M |
---|---|
Revenue (TTM) | $12.6M |
Shares Outstanding | 24.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.88 |
EPS | $-1.87 |
Book Value | $2.04 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 20.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -368.27% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.